Lupin Ltd. logo

Lupin Ltd. share price

NSE: LUPIN · Healthcare

₹1,976.70 -0.18%

Closing price data, updated 17 Nov 2026. 52-week range: -21.9% from high, +4.4% above low.

Price₹1,976.70
Market cap₹90,393 Cr
P/E17.4
P/B3.76
ROE26.9%
ROCE28.3%
Debt / equity0.29
Dividend yield0.00%
EPS₹113.85
Book value₹525.93
Operating margin24.8%
Dipscan score71 / 100
Open full analysis, charts & financials →

Share: WhatsAppX / TwitterTelegram

Lupin Ltd. shareholding pattern

As of Sep 2026: Promoters 46.84%, FIIs 23.28%, DIIs 23.78%, Government 0.00%, Public 5.13%, Others 0.96%.

HolderSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Promoters46.84%46.85%46.86%46.89%46.90%46.90%
FIIs23.28%22.42%21.71%21.49%20.49%21.25%
DIIs23.78%24.65%25.32%25.58%26.55%25.56%
Government0.00%0.00%0.00%0.01%0.01%0.01%
Public5.13%5.06%5.05%5.10%5.12%5.23%
Others0.96%1.02%1.06%0.93%0.94%1.05%
No. of Shareholders297,301300,283290,411288,931280,256286,604

As filed by the company with the exchanges.

Returns

1 day1 week1 month3 months6 months1 year
-0.18%-0.57%+1.20%-12.16%-12.47%+0.04%

Growth

Sales growth, 3 years+19.1%
Sales growth, 5 years–
Profit growth, 3 years+131.5%
Profit growth, 5 years–
Latest quarter sales vs last year–
Latest quarter profit vs last year–

Strengths and weaknesses

Strengths

Peers in Healthcare

CompanyPriceMarket capP/EROE1 year
Sun Pharmaceutical Industries ₹1,867.50₹4,48,076 Cr40.914.7%+8.8%
Divi's Laboratories Ltd.₹11,080.00₹2,94,139 Cr87.516.2%+69.4%
Torrent Pharmaceuticals Ltd.₹4,691.20₹1,78,438 Cr84.027.1%+22.6%
Apollo Hospitals Enterprise Lt₹8,771.00₹1,26,114 Cr56.221.9%+16.9%
Laurus Labs Ltd.₹2,220.00₹1,19,949 Cr89.518.2%+125.2%
Zydus Lifesciences Ltd.₹1,192.00₹1,18,902 Cr28.419.7%+27.0%
Dr. Reddy's Laboratories Ltd.₹1,377.90₹1,14,778 Cr41.012.1%+13.7%
Cipla Ltd.₹1,394.50₹1,12,658 Cr38.911.8%-8.0%

Frequently asked questions

What is the share price of Lupin Ltd.?

Lupin Ltd. (LUPIN) last closed at ₹1,976.70 (-0.18% on the day).

What is the market cap of Lupin Ltd.?

About ₹90,393 Cr.

What is the P/E ratio of Lupin Ltd.?

The price-to-earnings ratio is 17.4, and return on equity is 26.9%.

Figures are calculated from company results and exchange prices and are for information only.